|  
	    
           
           
            | Mediating 
              factor | Route | Effect 
              value | 95% 
              CI |   
            | Lower | Upper |   
            | DP | Exercise 
              intensity |   
            | No→DP→cognitive 
              decline | Reference |  |   
            | Light→DP→cognitive 
              decline | -0,002 | -0,013 | 0,006 |   
            | Moderate→DP→cognitive 
              decline | -0,004 | -0,020 | 0,009 |   
            | Vigorous→DP→cognitive 
              decline | -0,007 | -0,031 | 0,015 |   
            | Exercise 
              frequency |   
            | No→DP→cognitive 
              decline | Reference |  |   
            | Light, 
              1-5 days→DP→cognitive decline | -0,001 | -0,012 | 0,011 |   
            | Light, 
              6-7 days→DP→cognitive decline | -0,002 | -0,014 | 0,007 |   
            | Moderate, 
              1-5 days→DP→cognitive decline | -0,004 | -0,022 | 0,009 |   
            | Moderate, 
              6-7 days→DP→cognitive decline | -0,004 | -0,021 | 0,009 |   
            | Vigorous, 
              1-5 days→DP→cognitive decline | -0,008 | -0,037 | 0,017 |   
            | Vigorous, 
              6-7 days→DP→cognitive decline | -0,006 | -0,028 | 0,013 |   
            | PAC |   
            | Basic→DP→cognitive 
              decline | Reference |  |   
            | Increased 
              PAC Q1→DP→cognitive decline | -0,004 | -0,02 | 0,008 |   
            | Increased 
              PAC Q2→DP→cognitive decline | -0,003 | -0,015 | 0,006 |   
            | Increased 
              PAC Q3→DP→cognitive decline | -0,008 | -0,03 | 0,012 |   
            | Increased 
              PAC Q4→DP→cognitive decline | -0,007 | -0,029 | 0,011 |   
            | Sleep 
              duration | Exercise 
              intensity |   
            | No→sleep 
              duration→cognitive decline | Reference |  |   
            | Light→sleep 
              duration→cognitive decline | -0,003 | -0,017 | 0,007 |   
            | Moderate→sleep 
              duration→cognitive decline | -0,004 | -0,019 | 0,008 |   
            | Vigorous→sleep 
              duration→cognitive decline | -0,001 | -0,011 | 0,006 |   
            | Exercise 
              frequency |   
            | No→sleep 
              duration→cognitive decline | Reference |  |   
            | Light, 
              1-5 days→sleep duration→cognitive decline | -0,008 | -0,035 | 0,014 |   
            | Light, 
              6-7 days→sleep duration→cognitive decline | -0,002 | -0,013 | 0,006 |   
            | Moderate, 
              1-5 days→sleep duration→cognitive decline | -0,002 | -0,014 | 0,006 |   
            | Moderate, 
              6-7 days→sleep duration→cognitive decline | -0,005 | -0,023 | 0,009 |   
            | Vigorous, 
              1-5 days→sleep duration→cognitive decline | -0,001 | -0,011 | 0,006 |   
            | Vigorous, 
              6-7 days→sleep duration→cognitive decline | -0,001 | -0,01 | 0,006 |   
            | PAC |   
            | Basic→sleep 
              duration→cognitive decline | Reference |  |   
            | Increased 
              PAC Q1→sleep duration→cognitive decline | -0,003 | -0,016 | 0,007 |   
            | Increased 
              PAC Q2→sleep duration→cognitive decline | -0,003 | -0,017 | 0,008 |   
            | Increased 
              PAC Q3→sleep duration→cognitive decline | -0,004 | -0,019 | 0,009 |   
            | Increased 
              PAC Q4→sleep duration→cognitive decline | 0 | -0,008 | 0,007 |   
            | HbA1c | Exercise 
              intensity |   
            | No→HbA1c→cognitive 
              decline | Reference |  |   
            | Light→HbA1c→cognitive 
              decline | -0,0012 | -0,0139 | 0,0074 |   
            | Moderate→HbA1c→cognitive 
              decline | 0,0009 | -0,0099 | 0,0115 |   
            | Vigorous→HbA1c→cognitive 
              decline | -0,0017 | -0,0143 | 0,0058 |   
            | Exercise 
              frequency |   
            | No→HbA1c→cognitive 
              decline | Reference |  |   
            | Light, 
              1-5 days→HbA1c→cognitive decline | 0,001 | -0,016 | 0,018 |   
            | Light, 
              6-7 days→HbA1c→cognitive decline | -0,002 | -0,014 | 0,007 |   
            | Moderate, 
              1-5 days→HbA1c→cognitive decline | 0,007 | -0,005 | 0,029 |   
            | Moderate, 
              6-7 days→HbA1c→cognitive decline | -0,002 | -0,015 | 0,005 |   
            | Vigorous, 
              1-5 days→HbA1c→cognitive decline | -0,001 | -0,013 | 0,008 |   
            | Vigorous, 
              6-7 days→HbA1c→cognitive decline | -0,002 | -0,015 | 0,006 |   
            | PAC |   
            | Basic→HbA1c→cognitive 
              decline | Reference |  |   
            | Increased 
              PAC Q1→HbA1c→cognitive decline | 0 | -0,011 | 0,009 |   
            | Increased 
              PAC Q2→HbA1c→cognitive decline | -0,001 | -0,012 | 0,008 |   
            | Increased 
              PAC Q3→HbA1c→cognitive decline | 0 | -0,01 | 0,01 |   
            | Increased 
              PAC Q4→HbA1c→cognitive decline | -0,002 | -0,015 | 0,006 |   
            | Blood 
              glucose | Exercise 
              intensity |   
            | No→blood 
              glucose→cognitive decline | Reference |  |   
            | Light→blood 
              glucose→cognitive decline | -0,0024 | -0,0161 | 0,0048 |   
            | Moderate→blood 
              glucose→cognitive decline | -0,0022 | -0,0145 | 0,0057 |   
            | Vigorous→blood 
              glucose→cognitive decline | -0,0067 | -0,0232 | 0,0022 |   
            | Exercise 
              frequency |   
            | No→blood 
              glucose→cognitive decline | Reference |  |   
            | Light, 
              1-5 days→blood glucose→cognitive decline | -0,001 | -0,02 | 0,014 |   
            | Light, 
              6-7 days→blood glucose→cognitive decline | -0,003 | -0,016 | 0,005 |   
            | Moderate, 
              1-5 days→blood glucose→cognitive decline | -0,005 | -0,006 | 0,025 |   
            | Moderate, 
              6-7 days→blood glucose→cognitive decline | -0,006 | -0,023 | 0,002 |   
            | Vigorous, 
              1-5 days→blood glucose→cognitive decline | -0,007 | -0,025 | 0,003 |   
            | Vigorous, 
              6-7 days→blood glucose→cognitive decline | -0,006 | -0,023 | 0,003 |   
            | PAC |   
            | Basic→blood 
              glucose→cognitive decline | Reference |  |   
            | Increased 
              PAC Q1→blood glucose→cognitive decline | -0,002 | -0,015 | 0,005 |   
            | Increased 
              PAC Q2→blood glucose→cognitive decline | -0,004 | -0,019 | 0,004 |   
            | Increased 
              PAC Q3→blood glucose→cognitive decline | -0,003 | -0,018 | 0,004 |   
            | Increased 
              PAC Q4→blood glucose→cognitive decline | -0,006 | -0,023 | 0,002 |   
            | CESD | Exercise 
              intensity |   
            | No→cesd→cognitive 
              decline | Reference |  |   
            | Light→cesd→cognitive 
              decline | -0,007 | -0,0235 | 0,0035 |   
            | Moderate→cesd→cognitive 
              decline | -0,0072 | -0,0236 | 0,0033 |   
            | Vigorous→cesd→cognitive 
              decline | -0,0002 | -0,0111 | 0,0107 |   
            | Exercise 
              frequency |   
            | No→cesd→cognitive 
              decline | Reference |  |   
            | Light, 
              1-5 days→cesd→cognitive decline | 0,001 | -0,016 | 0,02 |   
            | Light, 
              6-7 days→cesd→cognitive decline | -0,009 | -0,027 | 0,003 |   
            | Moderate, 
              1-5 days→cesd→cognitive decline | -0,005 | -0,021 | 0,006 |   
            | Moderate, 
              6-7 days→cesd→cognitive decline | -0,009 | -0,027 | 0,003 |   
            | Vigorous, 
              1-5 days→cesd→cognitive decline | -0,002 | -0,015 | 0,01 |   
            | Vigorous, 
              6-7 days→cesd→cognitive decline | 0,001 | -0,01 | 0,014 |   
            | PAC |   
            | Basic→cesd→cognitive 
              decline | Reference |  |   
            | Increased 
              PAC Q1→cesd→cognitive decline | -0,0074 | -0,025 | 0,003 |   
            | Increased 
              PAC Q2→cesd→cognitive decline | -0,007 | -0,024 | 0,003 |   
            | Increased 
              PAC Q3→cesd→cognitive decline | -0,004 | -0,019 | 0,005 |   
            | Increased 
              PAC Q4→cesd→cognitive decline | 0,001 | -0,01 | 0,014 |   
            | Uric 
              acid | Exercise 
              intensity |   
            | No→uric 
              acid→cognitive decline | Reference |  |   
            | Light→uric 
              acid→cognitive decline | 0,017 | -0,003 | 0,044 |   
            | Moderate→uric 
              acid→cognitive decline | 0,005 | -0,004 | 0,02 |   
            | Vigorous→uric 
              acid→cognitive decline | 0,008 | -0,003 | 0,024 |   
            | Exercise 
              frequency |   
            | No→uric 
              acid→cognitive decline | Reference |  |   
            | Light, 
              1-5 days→uric acid→cognitive decline | 0,014 | -0,004 | 0,047 |   
            | Light, 
              6-7 days→uric acid→cognitive decline | 0,018 | -0,003 | 0,045 |   
            | Moderate, 
              1-5 days→uric acid→cognitive decline | 0,006 | -0,006 | 0,022 |   
            | Moderate, 
              6-7 days→uric acid→cognitive decline | 0,005 | -0,004 | 0,02 |   
            | Vigorous, 
              1-5 days→uric acid→cognitive decline | 0,005 | -0,005 | 0,021 |   
            | Vigorous, 
              6-7 days→uric acid→cognitive decline | 0,01 | -0,002 | 0,028 |   
            | PAC |   
            | Basic→uric 
              acid→cognitive decline | Reference |  |   
            | Increased 
              PAC Q1→uric acid→cognitive decline | 0,016 | -0,002 | 0,04 |   
            | Increased 
              PAC Q2→uric acid→cognitive decline | 0,011 | -0,002 | 0,031 |   
            | Increased 
              PAC Q3→uric acid→cognitive decline | 0,008 | -0,003 | 0,025 |   
            | Increased 
              PAC Q4→uric acid→cognitive decline | 0,005 | -0,005 | 0,02 |   
            | CRP | Exercise 
              intensity |   
            | No→CRP→cognitive 
              decline | Reference |  |   
            | Light→CRP→cognitive 
              decline | 0,001 | -0,006 | 0,009 |   
            | Moderate→CRP→cognitive 
              decline | 0,007 | -0,006 | 0,02 |   
            | Vigorous→CRP→cognitive 
              decline | 0,0002 | -0,006 | 0,009 |   
            | Exercise 
              frequency |   
            | No→CRP→cognitive 
              decline | Reference |  |   
            | Light, 
              1-5 days→CRP→cognitive decline | 0,008 | -0,009 | 0,028 |   
            | Light, 
              6-7 days→CRP→cognitive decline | 0 | -0,007 | 0,007 |   
            | Moderate, 
              1-5 days→CRP→cognitive decline | 0,007 | -0,005 | 0,026 |   
            | Moderate, 
              6-7 days→CRP→cognitive decline | 0,007 | -0,006 | 0,02 |   
            | Vigorous, 
              1-5 days→CRP→cognitive decline | 0,004 | -0,004 | 0,023 |   
            | Vigorous, 
              6-7 days→CRP→cognitive decline | -0,003 | -0,011 | 0,003 |   
            | PAC |   
            | Basic→CRP→cognitive 
              decline | Reference |  |   
            | Increased 
              PAC Q1→CRP→cognitive decline | 0,004 | -0,004 | 0,016 |   
            | Increased 
              PAC Q2→CRP→cognitive decline | 0,002 | -0,005 | 0,01 |   
            | Increased 
              PAC Q3→CRP→cognitive decline | 0,005 | -0,005 | 0,014 |   
            | Increased 
              PAC Q4→CRP→cognitive decline | 0 | -0,006 | 0,011 |   
            | NHDL-C | Exercise 
              intensity |   
            | No→NHDL-C→cognitive 
              decline | Reference |  |   
            | Light→NHDL-C→cognitive 
              decline | -0,004 | -0,018 | 0,005 |   
            | Moderate→NHDL-C→cognitive 
              decline | 0,001 | -0,008 | 0,012 |   
            | Vigorous→NHDL-C→cognitive 
              decline | 0,007 | -0,005 | 0,024 |   
            | Exercise 
              frequency |   
            | No→NHDL-C→cognitive 
              decline | Reference |  |   
            | Light, 
              1-5 days→NHDL-C→cognitive decline | -0,003 | -0,021 | 0,009 |   
            | Light, 
              6-7 days→NHDL-C→cognitive decline | -0,004 | -0,017 | 0,005 |   
            | Moderate, 
              1-5 days→NHDL-C→cognitive decline | -0,002 | -0,015 | 0,008 |   
            | Moderate, 
              6-7 days→NHDL-C→cognitive decline | 0,002 | -0,006 | 0,014 |   
            | Vigorous, 
              1-5 days→NHDL-C→cognitive decline | 0,007 | -0,006 | 0,025 |   
            | Vigorous, 
              6-7 days→NHDL-C→cognitive decline | 0,007 | -0,006 | 0,025 |   
            | PAC |   
            | Basic→NHDL-C→cognitive 
              decline | Reference |  |   
            | Increased 
              PAC Q1→NHDL-C→cognitive decline | -0,002 | -0,012 | 0,006 |   
            | Increased 
              PAC Q2→NHDL-C→cognitive decline | -0,003 | -0,017 | 0,005 |   
            | Increased 
              PAC Q3→NHDL-C→cognitive decline | 0,004 | -0,005 | 0,019 |   
            | Increased 
              PAC Q4→NHDL-C→cognitive decline | 0,007 | -0,007 | 0,026 |   
            | Triglyceride | Exercise 
              intensity |   
            | No→triglyceride→cognitive 
              decline | Reference |  |   
            | Light→triglyceride→cognitive 
              decline | 0,004 | -0,017 | 0,022 |   
            | Moderate→triglyceride→cognitive 
              decline | -0,001 | -0,012 | 0,006 |   
            | Vigorous→triglyceride→cognitive 
              decline | -0,001 | -0,013 | 0,006 |   
            | Exercise 
              frequency |   
            | No→triglyceride→cognitive 
              decline | Reference |  |   
            | Light, 
              1-5 days→triglyceride→cognitive decline | 0,002 | -0,013 | 0,015 |   
            | Light, 
              6-7 days→triglyceride→cognitive decline | 0,004 | -0,018 | 0,023 |   
            | Moderate, 
              1-5 days→triglyceride→cognitive decline | -0,001 | -0,01 | 0,007 |   
            | Moderate, 
              6-7 days→triglyceride→cognitive decline | -0,001 | -0,013 | 0,007 |   
            | Vigorous, 
              1-5 days→triglyceride→cognitive decline | -0,001 | -0,015 | 0,007 |   
            | Vigorous, 
              6-7 days→triglyceride→cognitive decline | -0,001 | -0,012 | 0,006 |   
            | PAC |   
            | Basic→triglyceride→cognitive 
              decline | Reference |  |   
            | Increased 
              PAC Q1→triglyceride→cognitive decline | 0,003 | -0,013 | 0,019 |   
            | Increased 
              PAC Q1→triglyceride→cognitive decline | 0 | -0,009 | 0,008 |   
            | Increased 
              PAC Q3→triglyceride→cognitive decline | -0,002 | -0,013 | 0,006 |   
            | Increased 
              PAC Q4→triglyceride→cognitive decline | -0,001 | -0,013 | 0,006 |  |